Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × Prednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 5 Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Lymphoma, Follicular 2 Endometrial Neoplasms 2 Burkitt Lymphoma 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Biphenotypic, Acute 1 Leukemia, B-Cell 1 Heart Failure 1 Dendritic Cell Sarcoma, Interdigitating 1 Colorectal Neoplasms 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1 Bulbo-Spinal Atrophy, X-Linked 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

Radiosurgery 23 Magnetic Resonance Spectroscopy 18 pembrolizumab 10 Temozolomide 10 Specimen Handling 8 Bevacizumab 8 Radiotherapy 5 Nivolumab 5 Magnetic Resonance Imaging 5 Ipilimumab 5 Cyclophosphamide 5 Neuropsychological Tests 4 Carboplatin 4 Capecitabine 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Radiation 3 Proton Therapy 3 Mental Status and Dementia Tests 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 binimetinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06471465 2025-08-17

BRADI

Institut Cancerologie de l'Ouest

Phase 3 Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡